COLUMBIA, Md., Jan 21, 2010 /PRNewswire via COMTEX News Network/ -- Martek Biosciences Corporation (Nasdaq: MATK) announced today that it has entered into an agreement to purchase Amerifit Brands Inc., a consumer health and wellness company, from Charterhouse Group, Inc. in an all-cash transaction valued at $200 million, subject to working capital...

COLUMBIA, Md., Dec 16, 2009 /PRNewswire-FirstCall via COMTEX News Network/ -- Martek Biosciences Corporation (Nasdaq: MATK) today announced its financial results for the fourth quarter and fiscal year ended October 31, 2009. Revenues for the fourth quarter were $87.6 million, down 3% from $90.4 million in the fourth quarter of fiscal 2008. Net inco...

COLUMBIA, Md., Dec 02, 2009 /PRNewswire-FirstCall via COMTEX News Network/ -- Martek Biosciences Corporation (Nasdaq: MATK) announced today that it intends to release the results of its fourth quarter and fiscal year 2009 on December 16, 2009, at approximately 4:00 p.m. Eastern Time (ET). Following the release, at 4:45 p.m. ET Martek will conduct ...

COLUMBIA, Md., Sept 16, 2009 /PRNewswire-FirstCall via COMTEX News Network/ -- Martek Biosciences (Nasdaq: MATK) today announced the election of David M. Pernock to its Board of Directors. Mr. Pernock brings to Martek's Board an extensive background in the commercialization of pharmaceutical products, having served from 1994 to 2009 in a variety o...

COLUMBIA, Md., Sept 10, 2009 /PRNewswire-FirstCall via COMTEX News Network/ -- DHA omega-3 innovator and maker of the life'sDHA(TM) brand, Martek Biosciences Corporation (Nasdaq: MATK), announced today it has resolved a patent dispute with Capsugel France. The resolution follows Martek's November 2008 action for infringement filed in the High Court...

COLUMBIA, Md., Sept 02, 2009 /PRNewswire-FirstCall via COMTEX News Network/ -- Martek Biosciences Corporation (Nasdaq: MATK) today announced its financial results for the third quarter of fiscal 2009. Revenues for the third quarter were $77.8 million, down 12% from $88.4 million in the third quarter of fiscal 2008. Net income was $8.9 million, or $...

COLUMBIA, Md., Aug 19, 2009 /PRNewswire-FirstCall via COMTEX News Network/ -- Martek Biosciences Corporation (Nasdaq: MATK) announced that it intends to release the results of its third quarter of fiscal 2009 on September 2, 2009, at approximately 4:00 p.m. Eastern Time (ET). Following the release, at 4:45 p.m. ET Martek will conduct a conference ...

COLUMBIA, Md., Aug 13, 2009 /PRNewswire-FirstCall via COMTEX News Network/ -- Martek Biosciences Corporation (Nasdaq: MATK) announced today that it has entered into a multi-year sole-source supply agreement with Puleva Food for the use of life'sARA(TM) in infant formulas produced by Puleva and sold in Spain. Puleva is part of the Ebro-Puleva group...

COLUMBIA, Md., July 28, 2009 /PRNewswire-FirstCall via COMTEX News Network/ -- Martek Biosciences Corporation (Nasdaq: MATK) announced today that it will be presenting at the Canaccord Adams 29th Annual Global Growth Conference which is scheduled to take place August 11-13, 2009 at the InterContinental Boston Hotel in Boston, MA. Steve Dubin, Chie...

COLUMBIA, Md., July 13, 2009 /PRNewswire-FirstCall via COMTEX News Network/ -- Martek Biosciences Corporation (Nasdaq: MATK) will conduct a conference call for investors to discussDHA research recently presented at the International Conference on Alzheimer's Disease. The call will take place July 13, 2009, at approximately 9 a.m. Eastern Time (ET)....